Sarcomas derived from GCN2−/− C57BL6 mice specifically demonstrated high levels of PERK activation, while sarcomas derived from GCN2−/− mixed background mice upregulated ATF4 even though eIF2α phosphorylation was reduced. The gene discussed is ATF4; the disease is sarcoma.